Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus Solifenacin

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04023253
Recruitment Status : Recruiting
First Posted : July 17, 2019
Last Update Posted : October 22, 2019
Sponsor:
Information provided by (Responsible Party):
Sheng-Mou Hsiao, Far Eastern Memorial Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 31, 2022
Estimated Study Completion Date : December 31, 2022